RELEASE: Tetra Pharm Technologies Opens New RD, Manufacturing and Production Facility

Tetra Pharm Technologies, a Danish biotech company, announces the completion of construction work on its new headquarters to support its long-term growth plans.

RELEASE: Tetra Pharm Technologies Opens New RD, Manufacturing and Production Facility

Tetra Pharm Technologies, a Danish biotech company, announces the completion of construction work on its new headquarters to support its long-term growth plans

COPENHAGEN, Denmark, Aug. 16, 2023 /PRNewswire/ -- Situated about 40 kilometers north of Copenhagen in Medicon Valley, the leading international life sciences cluster spanning the Greater Copenhagen region and southern Sweden, the new 4,000 square meter facility represents an important milestone in Tetra Pharm Technologies' plan for growth and expansion.

A former manufacturing site for medical solutions company Ambu A/S, the facility has undergone extensive construction and building upgrades to accommodate the specific needs of Tetra Pharm Technologies to expand its manufacturing capacity, strengthen and streamline its production capabilities and provide an optimal environment for the company's ambitious R&D activities.

"As a pharmaceutical company committed to improving the quality of life for our patients, the move to this state-of-the-art headquarters is a momentous event. The new location allows us to intensify our research and development efforts, expand and improve operational efficiencies and ultimately improve the accessibility of our innovative medicines to patients as part of our market expansion," said Martin Rose, CEO of Tetra Pharm Technologies.

The extensive facility offers Tetra Pharm Technologies the opportunity to cultivate a dynamic and collaborative work environment for its valued employees, enabling cross-functional teams to collaborate seamlessly.

Tetra Pharm Technologies will continue to operate at its current manufacturing and production facilities, located in Hillerød. The original plant will be converted into a dedicated pilot plant that will allow the company to conduct extensive tests, trials and evaluations without interfering with the operations of its new headquarters.

Martin Rose, CEO of Tetra Pharm Technologies, added: "We recognize the immense value of our original manufacturing and production facility, which has been the cradle of our company. Retaining it as a testing facility will allow us to preserve our strong focus on scientific innovation. for the benefit of our patients.

About Tetra Pharm Technologies

Tetra Pharm Technologies is a Danish biopharmaceutical company created in 2018 with the vision of being a leader in research and development of drugs for the treatment of diseases related to the endocannabinoid system.

For more information visit www.tetrapharm.eu

For more information

Martin Caspersencap@tetrapharm.eu 45 61224241

Photo - https://mma.prnewswire.com/media/2184861...Logo - https://mma.prnewswire.com/media/2184862...

View original content: https://www.prnewswire.com/news-releases/tetra-pharm-technologies-inaugura-nuevas-instalaciones-de-id-fabricacion-y-produccion-301899780.html

NEXT NEWS